April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
Targeting a cancer cell’s “master switch”
May 9, 2016 | City of Hope
According to a new study published in the prestigious scientific journal, Immunity, scientists at City of Hope have unlocked a key component of STAT3 activation, a gene that has long been associated with tumor cell growth and antitumor immune suppression. By exploring how STAT3 is activated in B cells, a major type of immune cell, our researchers have identified a novel target for cancer therapy.
Beating prostate cancer: ‘We’re taking off the brakes’
March 24, 2016 | City of Hope
Researchers at City of Hope believe they are on the verge of significant headway in the treatment of advanced prostate cancer, thanks to new thinking and “staggering” early success.
Antibodies discovery could revolutionize the treatment of cancer
February 2, 2016 | Elise Lamar
Stat, Myc, Myb, Fos, Ras, and Fox: Those bland monosyllables, unfamiliar to most of us, command the respect and fear of oncologists and cancer researchers worldwide. Why? Because they name proteins that drive uncontrollable cell division, metastasis, and/or drug resistance in numerous cancers.
March Grad Student Forum: Jenny Wang
March 21, 2014 | Jenny Wang
Successful breast cancer treatment is often hindered by chemoresistance, metastasis, and tumor recurrence. The existence of a small population of cells, called cancer stem cells, is thought to contribute to these complications.